Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis (Alimentary Pharmacology and Therapeutics, 2025)

(untitled) - Abbas, N; Smith, R; Lytvyak, E; Scraravaglio, M; Halliday, N; Almahroos, A; Eden, N; Lloyd‐Madden, D; Sharma, S; Ferguson, J; Dyson, JK; Thorburn, D; et al.